Centessa Pharmaceuticals plc
CNTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $51 | $44 | $105 | $383 |
| Short-Term Investments | $195 | $206 | $179 | $99 |
| Receivables | $52 | $44 | $53 | $45 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9 | $6 | $11 | $9 |
| Total Curr. Assets | $308 | $300 | $348 | $536 |
| Property Plant & Equip (Net) | $11 | $11 | $11 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $103 | $153 | $140 | $0 |
| Tax Assets | $25 | $25 | $26 | $27 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $141 | $192 | $180 | $40 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $448 | $492 | $528 | $577 |
| Liabilities | – | – | – | – |
| Payables | $9 | $6 | $5 | $7 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $20 | $23 | $17 | $50 |
| Total Curr. Liab. | $29 | $30 | $24 | $58 |
| LT Debt | $118 | $117 | $117 | $117 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $118 | $118 | $117 | $117 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $9 | $9 | $8 |
| Total Liabilities | $147 | $147 | $142 | $175 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,120 | -$1,065 | -$1,015 | -$989 |
| AOCI | $3 | $2 | $2 | $4 |
| Other Equity | $1,419 | $1,408 | $1,399 | $1,386 |
| Total Equity | $302 | $345 | $386 | $402 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $448 | $492 | $528 | $577 |
| Net Debt | $67 | $74 | $13 | -$266 |